V

Vall d'Hebron Barcelona Hospital Campus | Vall d'Hebron Hospital Universitario - Cardiology Department

Research site
(Unclaimed)
Location
Paseo Vall D`Hebron 119-129, Barcelona, Barcelona, Spain
Site insights

Top conditions

Enuresis (1 trial)

Mucopolysaccharidoses (1 trial)

Fetal Growth Retardation (1 trial)

Optic Neuritis (1 trial)

Infections (1 trial)

Top treatments

BX004-A

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

This is a Phase 1b/2a study with the primary objective to determine if BX004-A is safe and tolerable. Exploratory objectives include whether BX004-A...

Active, not recruiting
Cystic Fibrosis
Chronic Pseudomonas Aeruginosa Infection
Drug: BX004-A
Drug: Placebo

The main objective of this study is to evaluate the efficacy and safety of ABO-102 for the treatment of MPS IIIA.

Active, not recruiting
Sanfilippo A
MPS IIIA
Biological: ABO-102
Drug: Adjuvant Immunosuppression (IS) Therapy

Trial sponsors

V

Vall d'Hebron University Hospital (HUVH) (2 trials)

Ultragenyx logo

Ultragenyx (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems